D. Mark Anderson

Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption

D. Mark Anderson, Benjamin Hansen, Daniel I. Rees · The Journal of Law and Economics · 2013 · 419 citations

Public Health, Preventive Medicine, Drug Law +10

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 278 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study

Erica L. Mayer, Amylou C. Dueck, Miguel Martín et al. · The Lancet Oncology · 2021 · 255 citations

Medicine, Oncology, Pharmacology +15

In School and Out of Trouble? The Minimum Dropout Age and Juvenile Crime

D. Mark Anderson · The Review of Economics and Statistics · 2013 · 224 citations · Full text

Social Sciences, Criminology, Secondary Education +14

Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial

Harry H. Yoon, Johanna C. Bendell, Fadi S. Braiteh et al. · Annals of Oncology · 2016 · 144 citations · Full text

Medicine, Clinical Sciences, Oncology +13